ArticlePloS one2025
The role of affective temperaments in predicting depression and anxiety symptoms in patients with primary hyperparathyroidism.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study aimed to investigate the relationship between affective temperament traits and the severity of depression and anxiety symptoms in patients diagnosed with primary hyperparathyroidism.
methodsA cross-sectional study was conducted including 47 patients with primary hyperparathyroidism and 36 healthy controls. Participants were evaluated using the Memphis, Pisa, Paris and San Diego Temperament Assessment Scale to assess affective temperament profiles, and the Hospital Anxiety and Depression Scale to determine symptoms of anxiety and depression. Clinical, biochemical, and sociodemographic data were also collected. Correlation analyses and a generalized linear model were used to explore associations and predictors of psychiatric symptoms. Data were collected at Çanakkale Onsekiz Mart University between June 2016 and January 2017.
resultsPatients with primary hyperparathyroidism showed significantly higher scores for depressive, cyclothymic, and anxious temperaments compared to healthy controls. Anxiety and depression scores were also significantly higher in the patient group. Among patients, depressive, cyclothymic, irritable, and anxious temperament traits were positively correlated with both anxiety and depression levels, whereas hyperthymic temperament showed no significant association. Multivariate analysis revealed that anxious and cyclothymic temperaments were significant predictors of anxiety symptoms, while hyperthymic temperament was associated with lower depression scores. No significant associations were found between biochemical parameters and psychiatric symptom severity, except for a positive correlation between serum calcium levels and hyperthymic temperament.
conclusionsAffective temperament characteristics, particularly anxious and cyclothymic traits, are closely associated with the severity of anxiety and depression symptoms in patients with primary hyperparathyroidism. Hyperthymic temperament may act as a protective factor against depression in this population. Incorporating temperament assessment into the clinical evaluation of these patients may facilitate early identification of those at higher risk for psychiatric comorbidities and guide more effective, individualized intervention strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.